Sunrest Lifescience Ltd (NSE:SUNREST) Share Price

Company Profile

Business description
Sunrest Lifescience Ltd is engaged in the trading business of pharmaceutical products on a wholesale and retail basis. It deals in Capsules, Tablets, Syrup, Ointment, Gel, mouthwash, Solution, Suspension, Dry Powders, and Toothpaste. Its product portfolio comprises Analgesic & Anti Pyretic3030, Antacid Anti Emetics1414, Anti Biotics1717, Anti Cough & Cold4343, Anti Fungal2929, Anti Spasmodic & Enzyme99, Creams & Ointments44, Eye, Ear Drops & Nasal Spray88, General Products2828, Glucose & Energy Drink88, Hair Care77, Lady Care55, Multi Vitamins & Haemantinics3030, Oral Care55, Skin Care2222, and Vigor and Vitality.
Contact
Vastral Road
FF-41, Ajay Tenament-6 Near Canal
Near Ritanagar Bus Stand
AhmedabadGJ382415
IND
T: +91 7929918245
https://www.sunrestlifescience.com
Sector
Healthcare
Stock type
Defensive
Industry
Pharmaceutical Retailers
Fiscal Year End
31 March 2025
Employees
179

Recommended

Morningstar's Chief Investment Officer for Asia-Pacific and Director of Personal Finance share their thoughts on the recent RBA rate cut.

Matt Wacher | 21 February 2025

We’ve upgraded our fair value estimate for 29 companies, or 40% of those that have reported thus far.

Lochlan Halloway | 20 February 2025

Our analysts think these companies are undervalued and their shares appear to have the stamp of approval from highly rated managers.

Joseph Taylor | 20 February 2025

Index	Last price	Change	% Change
All Ordinaries	8,570.90	30.80	-0.36%
CAC 40	8,154.51	31.93	0.39%
DAX 40	22,287.56	27.09	-0.12%
Dow JONES (US)	43,725.89	450.76	-1.02%
FTSE 100	8,659.37	3.60	-0.04%
HKSE	23,477.92	900.94	3.99%
NASDAQ	19,764.02	198.34	-0.99%
Nikkei 225	38,776.94	98.90	0.26%
NZX 50 Index	12,752.58	127.78	-0.99%
S&P 500	6,071.32	46.20	-0.76%
S&P/ASX 200	8,296.20	26.60	-0.32%
SSE Composite Index	3,379.11	28.33	0.85%